Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
Frontiers in Neurology|June 26, 2020
Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG AntibodiesJae-Won Hyun, Young Nam Kwon, Sung-Min Kim, et al.Journal of the Neurological Sciences|July 19, 2017
A multicenter prospective observational study on the safety and efficacy of tacrolimus in patients with myasthenia gravisSuk-Won Ahn, In Soo Joo, Byung-Jo Kim, et al.JAMA Oncology|March 9, 2023
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical TrialTufia C Haddad, Vera J Suman, Antonino B D'Assoro, et al.Multiple Sclerosis and Related Disorders|August 12, 2019
Changing patterns of multiple sclerosis in Korea: Toward a more baseline MRI lesions and intrathecal humoral immune responsesHyun-June Shin, Jae-Won Hyun, Su-Hyun Kim, et al.Brain and Behavior|February 23, 2024
Clinical characteristics of persistent postural-perceptual dizziness and its visual subtype in Korean patients: A multicenter cross-sectional studyJoo Hyun Park, Thanh Tin Nguyen, Sung-Hee Kim, et al.Journal of Clinical Neurology (Seoul, Korea)|May 16, 2014
Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter studyJong Kuk Kim, Jong Seok Bae, Dae-Seong Kim, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated diseaseYou-Ri Kang, Hyunjin Ju, Ki Hoon Kim, et al.Journal of Clinical Neurology (Seoul, Korea)|March 11, 2025
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu-Hyun Kim, Ju-Hong Min, Sung-Min Kim, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2020
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae-Won Hyun, Hye Lim Lee, Woo Kyo Jeong, et al.JAMA Network Open|February 13, 2026
Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseHyunjin Ju, Ki Hoon Kim, Sook Young Woo, et al.Pageof 16